Related Experiment Video
Updated: Jun 15, 2026

Application of Retinoic Acid to Obtain Osteocytes Cultures from Primary Mouse Osteoblasts
Published on: May 13, 2014
Retinoid-suppressed phosphorylation of RARalpha mediates the differentiation pathway of osteosarcoma cells
1Department of Pathology, Childrens Hospital Los Angeles Saban Research Institute, Los Angeles, CA 90027, USA.
Abstract:
Although retinoic acid (RA) is a potent agent that coordinates inhibition of proliferation with differentiation of many cell types, RA-mediated signaling pathways in osteosarcoma cell differentiation are uncharacterized. In this study, we show that in human U2OS osteosarcoma cells, decreased phosphorylation of RA receptor alpha (RARalpha) by RA treatment or overexpressing a phosphorylation-defective mutant RARalphaS77A results in the inhibition of proliferation and induction of differentiation, and that U2OS cells transduced with RARalphaS77A suppresses tumor formation in nude mice. Moreover, using different human primary osteosarcoma cells and human mesenchymal stem cells for gene expression analysis, we found that either RA or RARalphaS77A induces many of the same differentiation response pathways and signaling molecules involved in U2OS cell differentiation. In addition, overexpression of the fibroblast growth factor 8f (FGF8f), one of the downstream targets induced by both RA and RARalphaS77A in U2OS cells, inhibits proliferation and induces expression of osteoblastic differentiation regulators. Hence, these data strongly suggest that RA-suppressed phosphorylation of RARalpha induces FGF8f expression to mediate differentiation response pathway in U2OS osteosarcoma cells.
Insights
Retinoic acid (RA) triggers osteosarcoma cell differentiation by reducing retinoic acid receptor alpha (RARalpha) phosphorylation. This pathway involves fibroblast growth factor 8f (FGF8f) induction, inhibiting proliferation and promoting osteoblastic differentiation.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Retinoic acid (RA) regulates cell proliferation and differentiation but its role in osteosarcoma is unclear.
- Osteosarcoma is a primary bone cancer with limited treatment options.
Purpose of the Study:
- To elucidate RA-mediated signaling pathways in human osteosarcoma cell differentiation.
- To investigate the role of retinoic acid receptor alpha (RARalpha) phosphorylation in osteosarcoma.
Main Methods:
- Utilized human U2OS osteosarcoma cells and primary osteosarcoma cells.
- Employed RA treatment, RARalpha phosphorylation-defective mutant (RARalphaS77A) overexpression, and gene expression analysis.
- Assessed tumor formation suppression in nude mice.
Main Results:
- Decreased RARalpha phosphorylation by RA or RARalphaS77A inhibited proliferation and induced differentiation in U2OS cells.
- RARalphaS77A overexpression suppressed tumor formation in vivo.
- RA and RARalphaS77A induced similar differentiation pathways in various osteosarcoma and stem cells.
- Fibroblast growth factor 8f (FGF8f) induction by RA/RARalphaS77A mediated osteoblastic differentiation.
Conclusions:
- RA-suppressed RARalpha phosphorylation is a key mechanism in osteosarcoma differentiation.
- FGF8f acts as a downstream mediator in the RA-induced differentiation pathway.
- Targeting RARalpha phosphorylation offers a potential therapeutic strategy for osteosarcoma.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway
TGF - β Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

